Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colonic Neoplasms × Drug Evaluation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Carcinoma, Basal Cell 2 Basal Cell Nevus Syndrome 2 Postmenopausal Women With ER+ HER2- Primary Breast Cancer 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Immunoglobulin Light-chain Amyloidosis 1 Glioma 1 Colonic Neoplasms 1 Breast Neoplasms 1 Amyloidosis 1

Interventions

Fluorouracil 127 Leucovorin 119 Oxaliplatin 100 Irinotecan 89 Bevacizumab 55 Cetuximab 44 Capecitabine 40 Folfox protocol 29 Panitumumab 22 Colonoscopy 17 Chemotherapy, Adjuvant 16 Floxuridine 15 Early Intervention, Educational 14 Erlotinib Hydrochloride 12 Surveys and Questionnaires 11 IFL protocol 11 Immunohistochemistry 10 Gemcitabine 10 Counseling 10 Psychiatric Rehabilitation 9 Celecoxib 9 Methods 8 Magnetic Resonance Spectroscopy 8 Gene Expression Profiling 8 Exercise 8 Dexamethasone 8 Cyclophosphamide 8 sargramostim 7 Sorafenib 7 Radiotherapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05189171 2024-06-28

MODEL-CRC

Xilis, Inc.

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡